Status:
ACTIVE_NOT_RECRUITING
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
Lead Sponsor:
ImmunityBio, Inc.
Conditions:
Non Muscle Invasive Bladder Cancer
Eligibility:
All Genders
Brief Summary
The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.
Detailed Description
All 9 subjects that completed QUILT-2.005 phase 1b are planned to be enrolled in this study. Thus, the maximum enrollment for this study is 9 subjects. All enrolled subjects will be followed every 12...
Eligibility Criteria
Inclusion
- Enrolled and treated with intravesical N-803 plus BCG in the phase 1b portion of QUILT-2.005.
Exclusion
- Not applicable
Key Trial Info
Start Date :
August 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2033
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05981131
Start Date
August 17 2023
End Date
August 30 2033
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Island Urology
Honolulu, Hawaii, United States, 96813